TuesdayAug 31, 2021 1:42 pm

FingerMotion Inc. (FNGR) Shares Progress on the NASDAQ Uplisting Application, Big Data Insights Division, in its August Corporate Update

On August 25, FingerMotion held a conference call in which it provided updates on the progress of its Sapientus division, application to uplist to the NASDAQ, and more Hosted by FingerMotion CEO Martin Shen, the corporate update also included a review of the Q1 2022 results, which marked the fourth consecutive quarter of record revenue FingerMotion received its first comment letter from NASDAQ, to which it responded promptly and efficiently The company, in collaboration with its partners, has begun translating products under the Sapientus division into an actual operational pilot FNGR will hold an AGM in November In July last…

Continue Reading

ThursdayAug 26, 2021 11:29 am

Infobird Co., Ltd (NASDAQ: IFBD) Capitalizing on the Growing Global SaaS Market Through Innovation and AI-Powered Solutions

The SaaS sector is projected to grow by $99.99 billion between 2021 and 2025 It is also projected that in the next few years, SaaS tools will exceed 50,000 globally Infobird is positioning itself to capitalize on this growth through innovation and its line of AI-powered solutions Its launch and successful implementation of the Intelligent Quality Inspection SaaS in July 2021 marks the company’s commitment to innovation and solving customer needs Infobird also continues to set itself apart by involving its customers in the development of Intelligent Quality Inspection SaaS Experts project that within the next few years, Software-as-a-Service (“SaaS”)…

Continue Reading

ThursdayAug 26, 2021 10:01 am

AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Names CEO of AnPac Bio U.S. to Drive Adoption of Early Cancer Detection Technology

Early cancer detection technology innovator AnPac Bio-Medical Science Co. Ltd. has been awarded 142 patents with 95 patents pending as part of its bid to revolutionize cancer screening protocols AnPac Bio’s proprietary technology screens for a variety of biophysical properties and analyzes the results to establish risk factors for tumor development before tumor cells begin circulating in the bloodstream AnPac Bio’s technology can be combined with the more extant tumor cell-detection technology to boost the screening’s effectiveness The international company, with operations in the US and China recently named an accomplished bio-medical executive, Dr. Sunil Pandit, as the CEO of…

Continue Reading

MondayAug 23, 2021 10:11 am

Infobird Co., Ltd (NASDAQ: IFBD) Boosts B2B Services with Launch of WeChat Call Center for Customer Development, Retention

China-based information technology company Infobird recently launched a WeChat call center designed to incorporate WeChat’s multi-channel functionality with Infobird’s SaaS platform for recruiting and retaining customers Infobird’s platform uses big data and AI to create “portraits” of consumers’ expectations and needs by analyzing input from multiple channels WeChat became the world's largest standalone mobile app in 2018 with over 1 billion monthly active users of its messaging, social media and mobile payment services Infobird’s cloud computing and AI technologies have generated more than 70 proprietary licensing rights The growth of China’s robust economic engine and the rapid modern development of…

Continue Reading

FridayAug 20, 2021 9:30 am

FingerMotion Inc. (FNGR), A 2021 Investor Relations Outlook

FingerMotion has maintained consistency in managing and communicating information to the public and investors throughout 2021 So far, it has held announcements covering its qualification to trade on the OTCQX Best Market, financial results updates, collaborations with other companies, and any upcoming conferences In line with maintaining this momentum, the company is set to host a corporate update call on August 25, 2021 The event, which is scheduled for 1:00 p.m. Eastern Time, will cover the company’s latest quarterly financial results, plans for an upcoming annual stockholders meeting, and the company’s application to have its shares listed on the Nasdaq…

Continue Reading

TuesdayAug 17, 2021 9:00 am

AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Announces New Cooperative and Partnership Agreements, and further Strengthens Board of Directors

Cooperation and partnership discussions: AnPac Bio has reported major corporations in the medical industry include Roche Pharmaceuticals China and Advanced Life Therapeutics Co., Ltd AnPac Bio holds 40% minority equity in Advanced Life Therapeutics, performing contract R&D on integrated circuit-based components for cancer treatment medical devices AnPac Bio’s board now includes Mr. Chao Feng who has global fortune 500 Companies’ managerial experience as independent director effective July 19, 2021 AnPac Bio-Medical Science (NASDAQ: ANPC), an innovative thought leader and biotechnology company focused on early screening and cancer detection by developing, distributing, and deploying accessible early disease detection devices, announced a…

Continue Reading

ThursdayAug 12, 2021 9:00 am

FingerMotion Inc. (FNGR) Schedules a Corporate Update Call for August 25 Against the Backdrop of Recent Positive Announcements

FingerMotion is planning to host a corporate update call on August 25 at 1 pm Eastern Time As part of the call, FNGR CEO Martin Shen is expected to cover recent developments, including the quarterly financial results, application to uplist to the NASDAQ, and plans for an upcoming annual meeting of shareholders A question-and-answer session is scheduled at the end of the call FingerMotion (OTCQX: FNGR), an evolving technology company with core competency in mobile payment solutions in China, as well as SMS/MMS, will be hosting a corporate update call scheduled for August 25, 2021, at 1 pm Eastern Time.…

Continue Reading

FridayAug 06, 2021 9:00 am

AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Announces Testing Volume Increase for First Half of 2021

Total number of paid tests and paid cancer tests increased significantly in Q2 over Q1 The company’s approach to multi-cancer screening is called Cancer Differentiation Analysis (“CDA”) that is powered by a database of over 200,000 samples and cases, changing the way to approach disease and cancer screenings The global cancer diagnostics market size is expected to reach $249.6 billion by 2026, growing at a CAGR of 7% during the forecast period AnPac Bio-Medical Science (NASDAQ: ANPC), a biotechnology company focused on early cancer screening, detection, and cancer treatment, announced that it experienced strong growth in test volume in the…

Continue Reading

ThursdayAug 05, 2021 1:40 pm

FingerMotion Inc. (FNGR) Applies for NASDAQ Uplisting

FingerMotion recently announced it has submitted an application to be uplisted to NASDAQ The company believes listing its shares of common stock on the Nasdaq Capital Market, which is subject to approval and fulfillment of applicable requirements, will improve liquidity, increase its corporate visibility, and enhance shareholder value FingerMotion’s first upgrade came in February 2019, when it announced it had been uplisted and approved to trade on the OTCQB Venture Marketplace In January 2021, the company was again uplisted to the OTCQX, where it currently trades and will continue trading until its application to join the NASDAQ is approved FingerMotion…

Continue Reading

MondayAug 02, 2021 9:30 am

AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Is ‘One to Watch’

AnPac Bio-Medical Science Co. Ltd. is a biotechnology company focused on early cancer screening and detection The company aims to develop, distribute and deploy its Cancer Differentiation Analysis (“CDA”) technology to change the way people approach cancer screening CDA is powered by a database of over 200,000 samples and cases, providing a new way to approach disease and cancer screening The company’s management team comprises professionals in both the United States and China who are knowledgeable and well educated in cancer screening and detection The global cancer diagnostics market is expected to reach $249.6 billion by 2026 AnPac Bio-Medical Science…

Continue Reading

Contact us: (310) 299-1717